Aneurysm Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Aneurysm Clinical Trials Market Report Overview
The aneurysm clinical trial market research report provides an overview of the aneurysm clinical trials scenario. The report provides top-line data relating to the clinical trials on the aneurysm. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Aneurysm Clinical Trials Market Segmentation by Regions and Countries
The key regions in the aneurysm clinical trials market are Asia-Pacific, Europe, North America, the Middle East & Africa, and South & Central America. The Asia-Pacific region dominates the market and is followed by the Europe and North America.
In a country-wise analysis, as of March 2023, the US has the highest number of aneurysm clinical trials, followed by Japan, China, the Netherlands, the UK, Australia, Canada, South Korea, Germany, and Denmark.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan has the highest proportion of aneurysm to cardiovascular clinical trials as of March 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China has the highest proportion of aneurysm to cardiovascular clinical trials as of March 2023.
Aneurysm Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Aneurysm clinical trials market, download a free report sample
Aneurysm Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the aneurysm clinical trials market are institution, company, and the government. Out of them, the institution sponsor type dominates the market, followed by company.
Aneurysm Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Aneurysm clinical trials market, download a free report sample
Aneurysm Clinical Trials Market - Competitive Landscape
The leading sponsors in the Aneurysm clinical trials market are CSL Ltd, Idorsia Pharmaceutical Ltd, AstraZeneca Plc, Medtronic Plc, Novartis AG, IQVIA Holdings Inc, Edge Therapeutics Inc (Inactive), F. Hoffmann-La Roche Ltd, Faron Pharmaceuticals Oy, and Hope Pharmaceuticals Inc. CSL Ltd has conducted the highest number of aneurysm clinical trials and is followed by Idorsia Pharmaceutical Ltd and AstraZeneca Plc.
Aneurysm Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the Aneurysm clinical trials market, download a free report sample
Aneurysm Clinical Trials Market Report Overview
| Key Regions | Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America |
| Key Countries | The US, Japan, China, the Netherlands, the UK, Australia, Canada, South Korea, Germany, and Denmark |
| Key Sponsor Types | Institution, Company, and Government |
| Leading Sponsors | CSL Ltd, Idorsia Pharmaceutical Ltd, AstraZeneca Plc, Medtronic Plc, Novartis AG, IQVIA Holdings Inc, Edge Therapeutics Inc (Inactive), F. Hoffmann-La Roche Ltd, Faron Pharmaceuticals Oy, and Hope Pharmaceuticals Inc |
Segments Covered in the Report
Aneurysm Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Aneurysm Clinical Trials Country Outlook (2023)
- The US
- Japan
- China
- The Netherlands
- The UK
- Australia
- Canada
- South Korea
- Germany
- Denmark
Aneurysm Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies regarding investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Idorsia Pharmaceutical Ltd
AstraZeneca Plc
Medtronic Plc
Novartis AG
IQVIA Holdings Inc
Edge Therapeutics Inc (Inactive)
F. Hoffmann-La Roche Ltd
Faron Pharmaceuticals Oy
Hope Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the aneurysm clinical trials market?
The key regions in the aneurysm clinical trials market are Asia-Pacific, Europe, North America, the Middle East & Africa, and South & Central America.
-
Which are the key countries in the aneurysm clinical trials market?
The key countries in the aneurysm clinical trials market are the US, Japan, China, the Netherlands, the UK, Australia, Canada, South Korea, Germany, and Denmark
-
What are the key sponsor types in the aneurysm clinical trials market?
The key sponsor types in the aneurysm clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the aneurysm clinical trials market?
The leading sponsors in the aneurysm clinical trials market are CSL Ltd, Idorsia Pharmaceutical Ltd, AstraZeneca Plc, Medtronic Plc, Novartis AG, IQVIA Holdings Inc, Edge Therapeutics Inc (Inactive), F. Hoffmann-La Roche Ltd, Faron Pharmaceuticals Oy, and Hope Pharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Aneurysm reports


